Washington Capital Management Inc Neurocrine Biosciences Inc Put Options Transaction History

Washington Capital Management Inc

  • $126 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Jul 11, 2023
BUY
$89.53 - $104.87 $67,147 - $78,652
750 Added 15.0%
5,750 $542,000
Q4 2022

Jan 18, 2023
SELL
$106.72 - $127.06 $160,080 - $190,590
-1,500 Reduced 23.08%
5,000 $0
Q3 2021

Nov 03, 2021
BUY
$86.18 - $99.03 $560,170 - $643,695
6,500 New
6,500 $623,000

Others Institutions Holding NBIX

# of Institutions
623
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Washington Capital Management Inc Portfolio

Follow Washington Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Washington Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email